Related Experiment Video
Updated: May 22, 2026
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic
Abigail L Stockham1, Andrew L Tievsky, Shlomo A Koyfman
1Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk T28, Cleveland, OH, 44195, USA. abigailstockham@gmail.com
Abstract:
Distinguishing radiation necrosis (RN) from tumor recurrence after stereotactic radiosurgery (SRS) for brain metastases is challenging. This study assesses the sensitivity (SN) and specificity (SP) of an MRI-based parameter, the "lesion quotient" (LQ), in characterizing tumor progression from RN. Records of patients treated with SRS for brain metastases between 01/01/1999 and 12/31/2009 and with histopathologic analysis of a subsequent contrast enhancing enlarging lesion at the treated site at a single institution were examined. The LQ, the ratio of maximal nodular cross sectional area on T2-weighted imaging to the corresponding maximal cross sectional area of T1-contrast enhancement, was calculated by a neuroradiologist blinded to the histopathological outcome. Cutoffs of <0.3, 0.3-0.6, and >0.6 have been previously suggested to have correlated with RN, mixed findings and tumor recurrence, respectively. These cutoff values were evaluated for SN, SP, positive predictive value (PPV) and negative predictive value (NPV). Logistic regression analysis evaluated for associated clinical factors. For the 51 patients evaluated, the SN, SP, PPV and NPV for identifying RN (LQ < 0.3) were 8, 91, 25 and 73 %, respectively. For the combination of recurrent tumor and RN (LQ 0.3-0.6) the SN, SP, PPV and NPV were 0, 64, 0 and 83 %. The SN, SP, PPV and NPV of the LQ for recurrent tumor (LQ > 0.6) were 59, 41, 62 and 39 %, respectively. Standard MRI techniques do not reliably discriminate between tumor progression and RN after treatment with SRS for brain metastases. Additional imaging modalities are warranted to aid in distinguishing between these diagnoses.
Insights
Distinguishing radiation necrosis from tumor recurrence after brain tumor treatment is difficult. The "lesion quotient" MRI parameter showed low reliability in differentiating these conditions, suggesting a need for advanced imaging methods.
Area of Science:
- Neuroradiology
- Oncology
- Medical Imaging
Background:
- Differentiating radiation necrosis (RN) from tumor recurrence after stereotactic radiosurgery (SRS) for brain metastases is a significant clinical challenge.
- Accurate diagnosis is crucial for appropriate patient management and treatment planning.
Purpose of the Study:
- To assess the diagnostic performance of the "lesion quotient" (LQ), an MRI-based parameter, in distinguishing between RN and tumor recurrence following SRS for brain metastases.
- To evaluate the sensitivity (SN), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV) of predefined LQ cutoffs.
Main Methods:
- Retrospective analysis of patients treated with SRS for brain metastases between 1999 and 2009, with subsequent histopathologic confirmation of enlarging lesions.
- Calculation of the LQ (ratio of T2-weighted nodular area to T1-contrast enhanced area) by a blinded neuroradiologist.
- Evaluation of LQ cutoffs (<0.3 for RN, 0.3-0.6 for mixed, >0.6 for recurrence) for diagnostic accuracy metrics.
Main Results:
- The LQ demonstrated poor performance in differentiating RN and tumor recurrence. For RN (LQ < 0.3), SN was 8% and SP was 91%.
- For tumor recurrence (LQ > 0.6), SN was 59% and SP was 41%.
- The LQ parameter showed low sensitivity and inconsistent specificity across different diagnostic categories, failing to reliably discriminate between RN and tumor recurrence.
Conclusions:
- Standard MRI-based "lesion quotient" is not a reliable method for distinguishing radiation necrosis from tumor recurrence after SRS for brain metastases.
- Further investigation into advanced or novel imaging modalities is warranted to improve diagnostic accuracy for post-SRS treatment changes.
Related Concept Videos
01:24Magnetic Resonance Imaging
01:14Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...